サンバイオの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/09/18 | 2,400 | 2,441 | 2,335 | 2,342 | -71 | -2.9% | 999,400 |
2025/09/17 | 2,303 | 2,517 | 2,295 | 2,413 | +89 | +3.8% | 1,978,200 |
2025/09/16 | 2,401 | 2,404 | 2,215 | 2,324 | -69 | -2.9% | 1,874,400 |
2025/09/12 | 2,398 | 2,420 | 2,355 | 2,393 | +32 | +1.4% | 736,300 |
2025/09/11 | 2,406 | 2,434 | 2,358 | 2,361 | -81 | -3.3% | 784,900 |
2025/09/10 | 2,461 | 2,475 | 2,415 | 2,442 | -19 | -0.8% | 510,900 |
2025/09/09 | 2,494 | 2,517 | 2,429 | 2,461 | -22 | -0.9% | 700,600 |
2025/09/08 | 2,500 | 2,566 | 2,475 | 2,483 | -2 | -0.1% | 1,278,500 |
2025/09/05 | 2,430 | 2,495 | 2,380 | 2,485 | +45 | +1.8% | 1,283,400 |
2025/09/04 | 2,413 | 2,447 | 2,371 | 2,440 | +38 | +1.6% | 906,200 |
2025/09/03 | 2,499 | 2,517 | 2,378 | 2,402 | -98 | -3.9% | 1,234,300 |
2025/09/02 | 2,420 | 2,571 | 2,377 | 2,500 | +95 | +4% | 2,222,200 |
2025/09/01 | 2,267 | 2,407 | 2,265 | 2,405 | +88 | +3.8% | 1,101,900 |
2025/08/29 | 2,323 | 2,364 | 2,315 | 2,317 | -6 | -0.3% | 858,600 |
2025/08/28 | 2,300 | 2,336 | 2,264 | 2,323 | +1 | ±0% | 942,700 |
2025/08/27 | 2,390 | 2,390 | 2,305 | 2,322 | -74 | -3.1% | 1,165,800 |
2025/08/26 | 2,420 | 2,431 | 2,378 | 2,396 | ±0 | ±0% | 1,170,100 |
2025/08/25 | 2,550 | 2,580 | 2,382 | 2,396 | -134 | -5.3% | 2,297,200 |
2025/08/22 | 2,508 | 2,590 | 2,508 | 2,530 | +24 | +1% | 1,351,500 |
2025/08/21 | 2,550 | 2,578 | 2,494 | 2,506 | -69 | -2.7% | 1,178,800 |
2025/08/20 | 2,595 | 2,619 | 2,557 | 2,575 | -31 | -1.2% | 1,334,500 |
2025/08/19 | 2,646 | 2,676 | 2,576 | 2,606 | -54 | -2% | 1,938,900 |
2025/08/18 | 2,671 | 2,737 | 2,644 | 2,660 | -35 | -1.3% | 2,187,300 |
2025/08/15 | 2,720 | 2,790 | 2,666 | 2,695 | -26 | -1% | 3,354,500 |
2025/08/14 | 2,727 | 2,780 | 2,669 | 2,721 | -34 | -1.2% | 2,095,200 |
2025/08/13 | 2,645 | 2,824 | 2,612 | 2,755 | +108 | +4.1% | 3,773,700 |
2025/08/12 | 2,748 | 2,849 | 2,642 | 2,647 | -80 | -2.9% | 4,209,400 |
2025/08/08 | 2,643 | 2,755 | 2,603 | 2,727 | +76 | +2.9% | 4,447,800 |
2025/08/07 | 2,467 | 2,708 | 2,427 | 2,651 | +206 | +8.4% | 6,397,100 |
2025/08/06 | 2,518 | 2,538 | 2,432 | 2,445 | -50 | -2% | 2,375,300 |
2025/08/05 | 2,350 | 2,500 | 2,346 | 2,495 | +160 | +6.9% | 2,912,100 |
2025/08/04 | 2,300 | 2,378 | 2,267 | 2,335 | -25 | -1.1% | 1,675,800 |
2025/08/01 | 2,286 | 2,406 | 2,275 | 2,360 | +45 | +1.9% | 2,582,400 |
2025/07/31 | 2,267 | 2,352 | 2,242 | 2,315 | +63 | +2.8% | 2,407,300 |
2025/07/30 | 2,307 | 2,310 | 2,195 | 2,252 | -54 | -2.3% | 2,201,700 |
2025/07/29 | 2,269 | 2,364 | 2,245 | 2,306 | +81 | +3.6% | 3,383,400 |
2025/07/28 | 2,341 | 2,356 | 2,220 | 2,225 | -143 | -6% | 3,288,000 |
2025/07/25 | 2,330 | 2,386 | 2,271 | 2,368 | +61 | +2.6% | 3,819,900 |
2025/07/24 | 2,214 | 2,340 | 2,183 | 2,307 | +143 | +6.6% | 3,394,600 |
2025/07/23 | 2,105 | 2,229 | 2,104 | 2,164 | +62 | +2.9% | 1,975,800 |
2025/07/22 | 2,148 | 2,215 | 2,102 | 2,102 | -11 | -0.5% | 1,873,400 |
2025/07/18 | 2,135 | 2,184 | 2,092 | 2,113 | -20 | -0.9% | 1,236,600 |
2025/07/17 | 2,082 | 2,162 | 2,082 | 2,133 | +52 | +2.5% | 1,552,600 |
2025/07/16 | 2,128 | 2,129 | 2,064 | 2,081 | -55 | -2.6% | 1,794,600 |
2025/07/15 | 2,185 | 2,333 | 2,125 | 2,136 | -31 | -1.4% | 3,411,500 |
2025/07/14 | 2,176 | 2,196 | 2,106 | 2,167 | +1 | ±0% | 1,445,700 |
2025/07/11 | 2,210 | 2,359 | 2,143 | 2,166 | -49 | -2.2% | 4,370,800 |
2025/07/10 | 2,086 | 2,280 | 2,075 | 2,215 | +136 | +6.5% | 6,209,500 |
2025/07/09 | 2,070 | 2,133 | 2,051 | 2,079 | +20 | +1% | 1,855,600 |
2025/07/08 | 2,129 | 2,153 | 2,040 | 2,059 | -60 | -2.8% | 1,856,600 |
1~
50
件表示中 / 2554件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サンバイオ | 234,200円 | - | - | 0.00% | - | 156.45倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
キッセイ薬 | 440,500円 | +3.6% | - | 2.72% | 14.85倍 | 0.87倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
科研薬 | 384,500円 | -6.4% | -71.8% | 4.94% | 42.82倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 299,100円 | +7.9% | -3.3% | 2.67% | 8.32倍 | 0.86倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 247,000円 | +21.7% | +999.9% | 0.00% | 11.38倍 | 3.89倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム